The Tolerance Tightrope
Every immune system walks a tightrope between two catastrophic failures: too little response lets infections kill; too much response attacks the body itself. Autoimmune disease occurs when this balance tips toward self-attack. Remarkably, all healthy people carry self-reactive T-cells and B-cells — the immune system does not eliminate every potentially dangerous cell, but instead maintains active suppression through regulatory mechanisms that keep autoreactivity below a critical threshold.
Layers of Tolerance
Immune tolerance operates at multiple levels. Central tolerance in the thymus eliminates T-cells that react too strongly to self-antigens (negative selection). But this process is imperfect — many self-reactive cells escape into the periphery. Peripheral tolerance mechanisms then take over: anergy (functional inactivation), deletion (activation-induced cell death), and active suppression by regulatory T-cells. This simulation models the critical balance between self-reactivity and Treg-mediated suppression.
Molecular Mimicry and Triggers
Infections can break tolerance through molecular mimicry — when pathogen proteins structurally resemble self-proteins, the anti-pathogen immune response cross-reacts with host tissues. Streptococcal M protein mimics cardiac myosin, causing rheumatic heart disease. Campylobacter lipooligosaccharides mimic nerve gangliosides, triggering Guillain-Barre syndrome. The mimicry parameter in this simulation models how pathogen similarity amplifies effective self-reactivity beyond the tolerance threshold.
Threshold Dynamics
Autoimmune disease is not simply present or absent — it follows threshold dynamics. As net autoreactivity approaches the critical threshold, tissue damage increases and clinical symptoms emerge gradually. Many patients experience flares and remissions as the balance shifts with infections, stress, and hormonal changes. Understanding these dynamics explains why autoimmune diseases are often episodic and why multiple risk factors must converge for clinical disease to manifest.